IVD Antibodies Market to Reach USD 2 Billion by 2032 at a 3.8% of CAGR

The global IVD antibodies market is projected to achieve a valuation of USD 1.38 billion by 2022, with an anticipated CAGR of 3.8% during the forecast period from 2022 to 2032. This growth is being fueled by the rising prevalence of chronic and infectious diseases worldwide and the increasing demand for early disease diagnosis to enable timely and effective treatment.

https://www.futuremarketinsigh....ts.com/reports/ivd-a